Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder

Sleep disturbance is commonly reported among individuals meeting criteria for cannabis use disorder (CUD), and cannabis users frequently report sleep disturbance as a contributor to failed quit attempts. The purpose of this study was to measure sleep in individuals enrolled in treatment for CUD, and to determine whether use of hypnotic medication during treatment increased abstinence rates.

Source: Journal of Substance Abuse Treatment - October 4, 2023 Category: Addiction Authors: Dustin C. Lee, Nicolas J. Schlienz, Evan S. Herrman, Erin L. Martin, Jeannie Leoutsakos, Alan J. Budney, Michael T. Smith, D. Andrew Tompkins, Aiden J. Hampson, Ryan Vandrey Source Type: research